$EKNL is on the edge of a HUGE breakout that can see prices

New Post Public Reply Private Reply Replies (0) Message Board

Dec 3, 2012 at 9:04 PM

$EKNL is on the edge of a HUGE breakout that can see prices soaring to multi-dollar land with KEY updates the company is expected to release from their marketing efforts from the recent Medical Conference in London – December is typically the best market gainer month if looking at the average returns over 40 years.

Interesting enough, the chart below shows the market indices performance by month with December booking the highest return month – these stocks made up primarily of large cap stocks but have a direct correlation impact on the penny stock market. With solid long term plays like EKNL, investors will definitely feel the December effect just as DROP did in 2011 reaching our $1.25 target bang on! With key breakout news ready to be unleashed, and super thin stock inventory, EKNL is primed for the biggest month on record!

The key to MEGA gains for EKNL in December is breakout trigger news and EKNL already hinted several times what the possible news can be – and we definitely expect it at any time!

We already got confirmation that the company met with key groups to finalize several deals and we expect these deals to be announced very soon.

“In addition to the hundreds of attendees who will be introduced to NCI products, NCI will be providing demonstrations to a number of parties who have expressed serious interest in FREMS and are attending to finalize purchasing arrangements” http://finance.yahoo.com/news/eko-internation...00594.html

This is definitely a very strong statement by the company to make, and making it is a solid hint that several Major contracts are practically done and ready to be unleashed. We are on HIGH ALERT for an update on these major contacts.

Definitely we can see additional major relationships following already announced agreement with iMD Network giving EKNL direct access to thousands of doctors for referrals of Diabetic patients with Neuropathy and the need of their FREMS equipment. Additionally, their NC Stat DPN testing devices are already in over 100 Walmart stores.

No doubt, if the NC Stat device is already in one store chain, the possibility of more Walmart stores and other chain to follow is pretty good. Not to mention, the company alluded to announcing which Walmart stores already deploy the NC Stat testing devices.

The Company will shortly be providing information on locations, including the WalMart pharmacies, where testing facilities are available for patients suffering from DPN.

EKNL also announced launching of clinics for their FREMS Technology including the Mayer Institute and their first of many clinics to be opened in the USA – this is a HUGE step forward for EKNL. Not only do they have a big presence in Canada, and even teaming up with 100 Walmart stores with the NC Stat Testing device, they just announced tapping into the US market which is absolutely HUGE.

EKO INTERNATIONAL INC. (the “Company”) – (EKNL) is pleased to announce that marketing efforts initiated prior to the Canadian Federation of Podiatric Medicine Conference held in London, Ontario on October 26th and 27th, 2012, have resulted in the preparation of clinical facilities in Chicago Illinois and Sault Ste. Marie, Ontario, Canada by health professionals to administer tests and to provide treatments for diabetic patients suffering from peripheral neuropathy.

No doubt, we can see a series of updates announcing more and more clinics being launched adding the base to increase their $$ bottom lines substantially.

EKNL already provided us with an update that the company is planning for uplisting and with MaloneBailey LLP, Certified Public Accounting Firm as auditors of the Company and the share buyback program already in place we can definitely see updates on their progress – Nasdaq bound listing may very well be close at hand.

And, No doubt with the share buyback program in effect, we are definitely keeping a very close eye on the active float of 5.5 million shares and expected reduction in this number.

There is one thing for sure, we expect significant news from EKNL and “No doubt” will see a flurry of update very soon. With $2 near term price target in sights, investors stand to more than triple gains at current trading levels which closed today at $0.50 and holding solid to over 1,200% gains for over 2 months since our initial alert at $0.04. Shares are in super strong hands definitely holding well into multi-dollar levels.

Key points that make EKNL an XTREME breakout play:

1) No dilution or insiders selling any time soon and especially at these super low prices.

2) Share buyback in effect. Definitely the reason here is to move prices up to proper valuations and big boards like Nasdaq requirements. We also got confirmation with recent announcement selecting MaloneBailey LLP, Certified Public Accounting Firm as auditors of the Company.

3) Super Low float. With only 5.5 Million active float (shares available at the DTC for trading), EKNL‘s share inventory is drying up super fast, and this is already triggering a MAJOR BULLISH BREAKOUT. We expect this number to significantly reduce as the company begins their buyback program.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Strategic Resources Faces Board Shakeup, AGM Announced

A Shift in Strategic Resources' Boardroom Dynamics On days like these, companies aren't just ticking boxes. They're repositioning themselves for a future painted with a whole bunch of ‘what ifs’, and Strategic Resources Inc. is no exception. This isn’t just your run-of-the-mill board shuffle—Michael Moore’s resignation marks a pivot moment. Now, you might ask...

Medefy's New Award Honors Cost-Savvy Consultants

Awarding Ingenuity in Healthcare Cost Containment Ditch the chatter, folks. Let’s talk about a little piece of news that just might be the ripple effect the healthcare sector needs right now. Medefy, that cost-containment whiz, has unleashed 'The Curve Bender Award.' Frankly, it's about time someone spotlighted the gritty work of benefits consultants grinding in the...

Ultrasound Innovations: 2D, 3D, and 4D Explained

Diving into the World of Ultrasound Imaging When you're in the trenches of expecting a new family member, the last thing you want is to get bogged down in technical jargon that doesn't make a lick of sense. Enter prenatal ultrasound imaging: 2D, 3D, and 4D. Each of these has a specific role in piecing together the puzzle of fetal development. Now, Erika Lambright, a...

New Ambulatory Surgery Center in Alabama Breaks Ground

Breaking New Ground: USOP and SOS Lead the Charge You can almost hear the construction noise starting up in Montgomery, Alabama, where U.S. Orthopaedic Partners (USOP) and Southern Orthopaedic Surgeons (SOS) have just launched an ambitious new project. They're not just cutting ceremonial ribbons; they're slicing into the future of orthopedic care in Central Alabama. The...

Sunshine Buns Gains Traction with Target Expansion

Frozen cinnamon rolls zapping to perfection in 45 seconds? Someone tell my breakfast table it's about to be revolutionized. Sunshine Buns is taking a giant leap into the spotlight as they hit the shelves of Target stores across the U.S. This isn’t just a nice little upturn—this is a potential game-changer for the frozen pastries aisle. A Sweet Deal Gets Sweeter Now,...

A.O. Smith Sells 81% of China Arm to CPE: Key Takeaways

When a major player like A.O. Smith decides to offload a piece of its business, folks tend to sit up and pay attention. This isn't just some run-of-the-mill shuffling. A.O. Smith has inked a deal with CPE to hand over an 81% stake in its China business. What does this transaction bring to the table and who stands to gain? Broken Down for the Curious Investor The numbers...

Everon Tops Industry: Integrator of the Year Win

Everon Claims the Coveted 2026 Integrator of the Year Award There's a new heavyweight in town, folks. Everon has snagged the Integrator of the Year award for 2026, and they're not just resting on their laurels about it. Named by industry titans NSCA, Commercial Integrator, and Security Sales & Integration, this accolade isn't just a flashy tick box—it’s a testament to...

Nakama's AniBiz Gains Power with New Investments

Anime Titans Back AniBiz Think of the anime sector with a new sheriff in town, and its name is AniBiz.com. This platform, a brainchild of Nakama, Inc., just landed strategic investments from some heavyweight players in the anime world: TBS Group, Toei Animation, and TV TOKYO Holdings. The Significance of Strategic Support Ain’t no small potatoes here. We're talking the...

CoCo Expands Bubble Tea Empire: Hungary to Ukraine

CoCo's Three-Market Strategy Dive into the world of bubbly enthusiasm: CoCo Bubble Tea is making a splash in Central and Eastern Europe, targeting Hungary, Armenia, and gearing up for Ukraine. No small feat, this move taps straight into the heart of younger consumers who can't get enough of quirky, customizable Asian-inspired drinks. We're not only talking tea—this is a...

Set Hach: A Leader Transforming Agrifood Systems

From Humble Beginnings to Global Recognition When a name like Set Hach doesn't just echo within local circles but reaches the global stage, you know something transformative is brewing. Here we have a woman celebrated as one of the 100 Women Heroes in Agrifood Systems by the UN Food and Agriculture Organization (FAO). Recognition like this speaks volumes, especially...